Literature DB >> 17148079

Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia.

Carita Eklund1, Reetta Huttunen, Jaana Syrjänen, Janne Laine, Risto Vuento, Mikko Hurme.   

Abstract

C-reactive protein (CRP) is an important molecule in the defence against bacterial infections. To discover if variation in the CRP gene is associated with clinical outcome of bacteraemia, we investigated 147 microbiologically verified bacteraemia patients (mean age 59 y, range 19-93 y) and determined whether CRP -717A>G, +1059G>C or +1444C>T single nucleotide polymorphisms (SNPs) were associated with clinical outcome of bacteraemia and/or CRP concentration caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-haemolytic streptococci or Escherichia coli. The patients were genotyped for CRP gene polymorphisms, CRP was measured and clinical outcomes were recorded. The CRP -717A>G, a promoter region polymorphism was strongly associated with mortality from Streptococcus pneumoniae but did not correlate with plasma CRP concentration. These results suggest that mortality from Streptococcus pneumoniae may be associated with polymorphism of the promoter region of the CRP gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148079     DOI: 10.1080/00365540600978922

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patients.

Authors:  Peter Yam-Kau Poon; Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

2.  Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

Authors:  B D Freeman; C R Kennedy; H L Frankel; B Clarridge; D Bolcic-Jankovic; E Iverson; E Shehane; A Celious; B A Zehnbauer; T G Buchman
Journal:  Pharmacogenomics J       Date:  2009-12-08       Impact factor: 3.550

3.  Genetic polymorphism of the C-reactive protein (CRP) gene and a deep infection focus determine maximal serum CRP level in Staphylococcus aureus bacteremia.

Authors:  T Mölkänen; A Rostila; E Ruotsalainen; M Alanne; M Perola; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-16       Impact factor: 3.267

4.  The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes.

Authors:  Rosalyn Casey; Jane Newcombe; Johnjoe McFadden; Katherine B Bodman-Smith
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

5.  Individualized significance of the -251 A/T single nucleotide polymorphism of interleukin-8 in severe infections.

Authors:  M D Georgitsi; V Vitoros; C Panou; I Tsangaris; E Aimoniotou; N K Gatselis; E Chasou; G Kouliatsis; K Leventogiannis; D Velissaris; E Belesiotou; O Dioritou-Aggaliadou; E Giannitsioti; M G Netea; E J Giamarellos-Bourboulis; G Giannikopoulos; Z Alexiou; N Voloudakis; A Koutsoukou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-14       Impact factor: 3.267

6.  C-reactive protein is essential for innate resistance to pneumococcal infection.

Authors:  J Paul Simons; Jutta M Loeffler; Raya Al-Shawi; Stephan Ellmerich; Winston L Hutchinson; Glenys A Tennent; Aviva Petrie; John G Raynes; J Brian de Souza; Rachel A Lawrence; Kevin D Read; Mark B Pepys
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Host genetic variability and pneumococcal disease: a systematic review and meta-analysis.

Authors:  Anne T Kloek; Matthijs C Brouwer; Diederik van de Beek
Journal:  BMC Med Genomics       Date:  2019-09-13       Impact factor: 3.063

8.  Spir2; a novel QTL on chromosome 4 contributes to susceptibility to pneumococcal infection in mice.

Authors:  Laura Wisby; Vitor E Fernandes; Daniel R Neill; Aras Kadioglu; Peter W Andrew; Paul Denny
Journal:  BMC Genomics       Date:  2013-04-11       Impact factor: 3.969

Review 9.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.